Pfizer reported fourth-quarter earnings and revenue that beat expectations, driven by stronger-than-expected Covid product sales and cost-cutting efforts. The company posted adjusted earnings per share of 63 cents, surpassing the expected 46 cents, with revenue reaching $17.76 billion, higher than the $17.36 billion forecasted. Shares of Pfizer rose 2% in premarket trading. The company has been cutting costs to recover from the decline of its … Continue reading Pfizer tops earnings estimates as Covid product sales beat expectations